Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

ASSET - AI for Sustainable Prevention of Autoimmunity in the Society

Reference number
Coordinator Diamyd Medical AB
Funding from Vinnova SEK 39 702 296
Project duration September 2021 - September 2026
Status Ongoing
Venture Innovationsmiljöer inom precisionshälsa
Call Innovation milieus in precision Health 2021

Important results from the project

ASSET built a precision-health chain from data to clinic. AI models were developed that estimate the individual time to type 1 diabetes onset, as well as a proposed system for individualised monitoring. The TUPP pilot study tested child-health-centre screening for autoimmune diseases, and DiaPrecise treated individuals with precision medicine. The project created a lasting forum for care, research, patients, authorities and companies. Core goals were met, but some sub-goals were not completed.

Expected long term effects

ASSET can contribute to the development of precision health in Swedish healthcare through individualised identification and monitoring of disease risk using AI. AI support, pilot studies and collaboration provide a basis for the continued development of organised screening, highlight possible synergies and efficiencies, and improve the conditions for preventive action. Over time this may prevent and reduce the severe consequences of disease and lower costs for society.

Approach and implementation

ASSET brought together companies, academia and healthcare around data, clinical pilots and healthcare conditions. TEDDY data were used to develop AI-based risk models. TUPP tested child-health-centre sampling and DiaPrecise tested targeted immunotherapy before onset. Recurring conferences and round-tables gathered patients, care, researchers, authorities and companies. The learnings were summarised in the dialogue material “Framtidens screening”. A steering group supported the work throughout.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 5 November 2026

Reference number 2021-02684